Table of Contents 1 Large Volume Parenteral (LVP) Market Overview 1.1 Product Overview and Scope of Large Volume Parenteral (LVP) 1.2 Large Volume Parenteral (LVP) Segment by Type 1.2.1 Global Large Volume Parenteral (LVP) Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Soft Bag LVP 1.2.3 Plastic Bottle LVP 1.2.4 Glass Bottle LVP 1.3 Large Volume Parenteral (LVP) Segment by Application 1.3.1 Large Volume Parenteral (LVP) Sales Comparison by Application: 2020 VS 2026 1.3.2 Basic Infusion 1.3.3 Therapeutic Infusion 1.3.4 Nutritious Infusion 1.4 Global Large Volume Parenteral (LVP) Market Size Estimates and Forecasts 1.4.1 Global Large Volume Parenteral (LVP) Revenue 2015-2026 1.4.2 Global Large Volume Parenteral (LVP) Sales 2015-2026 1.4.3 Large Volume Parenteral (LVP) Market Size by Region: 2020 Versus 2026 2 Global Large Volume Parenteral (LVP) Market Competition by Manufacturers 2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2015-2020) 2.2 Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2015-2020) 2.3 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites, Area Served, Product Type 2.5 Large Volume Parenteral (LVP) Market Competitive Situation and Trends 2.5.1 Large Volume Parenteral (LVP) Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Large Volume Parenteral (LVP) Players (Opinion Leaders) 3 Large Volume Parenteral (LVP) Retrospective Market Scenario by Region 3.1 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country 3.3.1 North America Large Volume Parenteral (LVP) Sales by Country 3.3.2 North America Large Volume Parenteral (LVP) Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country 3.4.1 Europe Large Volume Parenteral (LVP) Sales by Country 3.4.2 Europe Large Volume Parenteral (LVP) Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Region 3.5.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Region 3.5.2 Asia Pacific Large Volume Parenteral (LVP) Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country 3.6.1 Latin America Large Volume Parenteral (LVP) Sales by Country 3.6.2 Latin America Large Volume Parenteral (LVP) Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country 3.7.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country 3.7.2 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Large Volume Parenteral (LVP) Historic Market Analysis by Type 4.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2015-2020) 4.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2015-2020) 4.3 Global Large Volume Parenteral (LVP) Price Market Share by Type (2015-2020) 4.4 Global Large Volume Parenteral (LVP) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Large Volume Parenteral (LVP) Historic Market Analysis by Application 5.1 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2015-2020) 5.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2015-2020) 5.3 Global Large Volume Parenteral (LVP) Price by Application (2015-2020) 6 Company Profiles and Key Figures in Large Volume Parenteral (LVP) Business 6.1 Baxter Healthcare 6.1.1 Corporation Information 6.1.2 Baxter Healthcare Description, Business Overview and Total Revenue 6.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Baxter Healthcare Products Offered 6.1.5 Baxter Healthcare Recent Development 6.2 Kelun Pharma 6.2.1 Kelun Pharma Large Volume Parenteral (LVP) Production Sites and Area Served 6.2.2 Kelun Pharma Description, Business Overview and Total Revenue 6.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Kelun Pharma Products Offered 6.2.5 Kelun Pharma Recent Development 6.3 B. Braun 6.3.1 B. Braun Large Volume Parenteral (LVP) Production Sites and Area Served 6.3.2 B. Braun Description, Business Overview and Total Revenue 6.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.3.4 B. Braun Products Offered 6.3.5 B. Braun Recent Development 6.4 Fresenius 6.4.1 Fresenius Large Volume Parenteral (LVP) Production Sites and Area Served 6.4.2 Fresenius Description, Business Overview and Total Revenue 6.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Fresenius Products Offered 6.4.5 Fresenius Recent Development 6.5 Teva Pharmaceutical Industries 6.5.1 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Production Sites and Area Served 6.5.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue 6.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Teva Pharmaceutical Industries Products Offered 6.5.5 Teva Pharmaceutical Industries Recent Development 6.6 Pfizer (Hospira) 6.6.1 Pfizer (Hospira) Large Volume Parenteral (LVP) Production Sites and Area Served 6.6.2 Pfizer (Hospira) Description, Business Overview and Total Revenue 6.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Pfizer (Hospira) Products Offered 6.6.5 Pfizer (Hospira) Recent Development 6.7 Ostuka Pharmaceutical 6.6.1 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Production Sites and Area Served 6.6.2 Ostuka Pharmaceutical Description, Business Overview and Total Revenue 6.6.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Ostuka Pharmaceutical Products Offered 6.7.5 Ostuka Pharmaceutical Recent Development 6.8 CR Double-Crane 6.8.1 CR Double-Crane Large Volume Parenteral (LVP) Production Sites and Area Served 6.8.2 CR Double-Crane Description, Business Overview and Total Revenue 6.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.8.4 CR Double-Crane Products Offered 6.8.5 CR Double-Crane Recent Development 6.9 Pisa 6.9.1 Pisa Large Volume Parenteral (LVP) Production Sites and Area Served 6.9.2 Pisa Description, Business Overview and Total Revenue 6.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Pisa Products Offered 6.9.5 Pisa Recent Development 6.10 Huaren 6.10.1 Huaren Large Volume Parenteral (LVP) Production Sites and Area Served 6.10.2 Huaren Description, Business Overview and Total Revenue 6.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Huaren Products Offered 6.10.5 Huaren Recent Development 6.11 Patheon 6.11.1 Patheon Large Volume Parenteral (LVP) Production Sites and Area Served 6.11.2 Patheon Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue 6.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Patheon Products Offered 6.11.5 Patheon Recent Development 6.12 Aspen Holdings 6.12.1 Aspen Holdings Large Volume Parenteral (LVP) Production Sites and Area Served 6.12.2 Aspen Holdings Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue 6.12.3 Aspen Holdings Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Aspen Holdings Products Offered 6.12.5 Aspen Holdings Recent Development 6.13 Beximco Pharma 6.13.1 Beximco Pharma Large Volume Parenteral (LVP) Production Sites and Area Served 6.13.2 Beximco Pharma Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue 6.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Beximco Pharma Products Offered 6.13.5 Beximco Pharma Recent Development 6.14 Cook Pharmica 6.14.1 Cook Pharmica Large Volume Parenteral (LVP) Production Sites and Area Served 6.14.2 Cook Pharmica Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue 6.14.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Cook Pharmica Products Offered 6.14.5 Cook Pharmica Recent Development 6.15 Albert David 6.15.1 Albert David Large Volume Parenteral (LVP) Production Sites and Area Served 6.15.2 Albert David Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue 6.15.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.15.4 Albert David Products Offered 6.15.5 Albert David Recent Development 6.16 PSI Ltd 6.16.1 PSI Ltd Large Volume Parenteral (LVP) Production Sites and Area Served 6.16.2 PSI Ltd Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue 6.16.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.16.4 PSI Ltd Products Offered 6.16.5 PSI Ltd Recent Development 6.17 Ozon Pharmaceuticals 6.17.1 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Production Sites and Area Served 6.17.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue 6.17.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.17.4 Ozon Pharmaceuticals Products Offered 6.17.5 Ozon Pharmaceuticals Recent Development 6.18 BAG Healthcare 6.18.1 BAG Healthcare Large Volume Parenteral (LVP) Production Sites and Area Served 6.18.2 BAG Healthcare Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue 6.18.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.18.4 BAG Healthcare Products Offered 6.18.5 BAG Healthcare Recent Development 6.19 BML Parenteral Drugs 6.19.1 BML Parenteral Drugs Large Volume Parenteral (LVP) Production Sites and Area Served 6.19.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue 6.19.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020) 6.19.4 BML Parenteral Drugs Products Offered 6.19.5 BML Parenteral Drugs Recent Development 7 Large Volume Parenteral (LVP) Manufacturing Cost Analysis 7.1 Large Volume Parenteral (LVP) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP) 7.4 Large Volume Parenteral (LVP) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Large Volume Parenteral (LVP) Distributors List 8.3 Large Volume Parenteral (LVP) Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Large Volume Parenteral (LVP) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Type (2021-2026) 10.2 Large Volume Parenteral (LVP) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Application (2021-2026) 10.3 Large Volume Parenteral (LVP) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Region (2021-2026) 10.4 North America Large Volume Parenteral (LVP) Estimates and Projections (2021-2026) 10.5 Europe Large Volume Parenteral (LVP) Estimates and Projections (2021-2026) 10.6 Asia Pacific Large Volume Parenteral (LVP) Estimates and Projections (2021-2026) 10.7 Latin America Large Volume Parenteral (LVP) Estimates and Projections (2021-2026) 10.8 Middle East and Africa Large Volume Parenteral (LVP) Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Large Volume Parenteral (LVP) Sales (M Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Large Volume Parenteral (LVP) Sales (M Units) Comparison by Application: 2020 VS 2026 Table 3. Global Large Volume Parenteral (LVP) Market Size by Type (M Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Large Volume Parenteral (LVP) Manufacturers Covered in This Study Table 5. Global Large Volume Parenteral (LVP) Sales (M Units) by Manufacturers (2015-2020) Table 6. Global Large Volume Parenteral (LVP) Sales Share by Manufacturers (2015-2020) Table 7. Global Large Volume Parenteral (LVP) Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Large Volume Parenteral (LVP) Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Large Volume Parenteral (LVP) Sales Sites and Area Served Table 11. Manufacturers Large Volume Parenteral (LVP) Product Types Table 12. Global Large Volume Parenteral (LVP) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Volume Parenteral (LVP) as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Large Volume Parenteral (LVP) Players Table 16. Global Large Volume Parenteral (LVP) Sales (M Units) by Region (2015-2020) Table 17. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2015-2020) Table 18. Global Large Volume Parenteral (LVP) Revenue (Million US$) by Region (2015-2020) Table 19. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2015-2020) Table 20. North America Large Volume Parenteral (LVP) Sales by Country (2015-2020) (M Units) Table 21. North America Large Volume Parenteral (LVP) Sales Market Share by Country (2015-2020) Table 22. North America Large Volume Parenteral (LVP) Revenue by Country (2015-2020) (US$ Million) Table 23. North America Large Volume Parenteral (LVP) Revenue Market Share by Country (2015-2020) Table 24. Europe Large Volume Parenteral (LVP) Sales by Country (2015-2020) (M Units) Table 25. Europe Large Volume Parenteral (LVP) Sales Market Share by Country (2015-2020) Table 26. Europe Large Volume Parenteral (LVP) Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2015-2020) (M Units) Table 29. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Region (2015-2020) Table 32. Latin America Large Volume Parenteral (LVP) Sales by Country (2015-2020) (M Units) Table 33. Latin America Large Volume Parenteral (LVP) Sales Market Share by Country (2015-2020) Table 34. Latin America Large Volume Parenteral (LVP) Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2015-2020) (M Units) Table 37. Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Country (2015-2020) Table 40. Global Large Volume Parenteral (LVP) Sales (M Units) by Type (2015-2020) Table 41. Global Large Volume Parenteral (LVP) Sales Share by Type (2015-2020) Table 42. Global Large Volume Parenteral (LVP) Revenue (Million US$) by Type (2015-2020) Table 43. Global Large Volume Parenteral (LVP) Revenue Share by Type (2015-2020) Table 44. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Type (2015-2020) Table 45. Global Large Volume Parenteral (LVP) Sales (M Units) by Application (2015-2020) Table 46. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2015-2020) Table 47. Global Large Volume Parenteral (LVP) Sales Growth Rate by Application (2015-2020) Table 48. Baxter Healthcare Large Volume Parenteral (LVP) Corporation Information Table 49. Baxter Healthcare Description and Business Overview Table 50. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Baxter Healthcare Main Product Table 52. Baxter Healthcare Recent Development Table 53. Kelun Pharma Large Volume Parenteral (LVP) Corporation Information Table 54. Kelun Pharma Corporation Information Table 55. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Kelun Pharma Main Product Table 57. Kelun Pharma Recent Development Table 58. B. Braun Large Volume Parenteral (LVP) Corporation Information Table 59. B. Braun Corporation Information Table 60. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. B. Braun Main Product Table 62. B. Braun Recent Development Table 63. Fresenius Large Volume Parenteral (LVP) Corporation Information Table 64. Fresenius Corporation Information Table 65. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Fresenius Main Product Table 67. Fresenius Recent Development Table 68. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Corporation Information Table 69. Teva Pharmaceutical Industries Corporation Information Table 70. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Teva Pharmaceutical Industries Main Product Table 72. Teva Pharmaceutical Industries Recent Development Table 73. Pfizer (Hospira) Large Volume Parenteral (LVP) Corporation Information Table 74. Pfizer (Hospira) Corporation Information Table 75. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Pfizer (Hospira) Main Product Table 77. Pfizer (Hospira) Recent Development Table 78. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Corporation Information Table 79. Ostuka Pharmaceutical Corporation Information Table 80. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Ostuka Pharmaceutical Main Product Table 82. Ostuka Pharmaceutical Recent Development Table 83. CR Double-Crane Large Volume Parenteral (LVP) Corporation Information Table 84. CR Double-Crane Corporation Information Table 85. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. CR Double-Crane Main Product Table 87. CR Double-Crane Recent Development Table 88. Pisa Large Volume Parenteral (LVP) Corporation Information Table 89. Pisa Corporation Information Table 90. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Pisa Main Product Table 92. Pisa Recent Development Table 93. Huaren Large Volume Parenteral (LVP) Corporation Information Table 94. Huaren Corporation Information Table 95. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 96. Huaren Main Product Table 97. Huaren Recent Development Table 98. Patheon Large Volume Parenteral (LVP) Corporation Information Table 99. Patheon Corporation Information Table 100. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 101. Patheon Main Product Table 102. Patheon Recent Development Table 103. Aspen Holdings Large Volume Parenteral (LVP) Corporation Information Table 104. Aspen Holdings Corporation Information Table 105. Aspen Holdings Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 106. Aspen Holdings Main Product Table 107. Aspen Holdings Recent Development Table 108. Beximco Pharma Large Volume Parenteral (LVP) Corporation Information Table 109. Beximco Pharma Corporation Information Table 110. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 111. Beximco Pharma Main Product Table 112. Beximco Pharma Recent Development Table 113. Cook Pharmica Large Volume Parenteral (LVP) Corporation Information Table 114. Cook Pharmica Corporation Information Table 115. Cook Pharmica Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 116. Cook Pharmica Main Product Table 117. Cook Pharmica Recent Development Table 118. Albert David Large Volume Parenteral (LVP) Corporation Information Table 119. Albert David Corporation Information Table 120. Albert David Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 121. Albert David Main Product Table 122. Albert David Recent Development Table 123. PSI Ltd Large Volume Parenteral (LVP) Corporation Information Table 124. PSI Ltd Corporation Information Table 125. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 126. PSI Ltd Main Product Table 127. PSI Ltd Recent Development Table 128. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Corporation Information Table 129. Ozon Pharmaceuticals Corporation Information Table 130. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 131. Ozon Pharmaceuticals Main Product Table 132. Ozon Pharmaceuticals Recent Development Table 133. BAG Healthcare Large Volume Parenteral (LVP) Corporation Information Table 134. BAG Healthcare Corporation Information Table 135. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 136. BAG Healthcare Main Product Table 137. BAG Healthcare Recent Development Table 138. BML Parenteral Drugs Large Volume Parenteral (LVP) Corporation Information Table 139. BML Parenteral Drugs Corporation Information Table 140. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 141. BML Parenteral Drugs Main Product Table 142. BML Parenteral Drugs Recent Development Table 143. Sales Base and Market Concentration Rate of Raw Material Table 144. Key Suppliers of Raw Materials Table 145. Large Volume Parenteral (LVP) Distributors List Table 146. Large Volume Parenteral (LVP) Customers List Table 147. Market Key Trends Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 149. Key Challenges Table 150. Global Large Volume Parenteral (LVP) Sales (M Units) Forecast by Type (2021-2026) Table 151. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Type (2021-2026) Table 152. Global Large Volume Parenteral (LVP) Revenue (Million US$) Forecast by Type (2021-2026) Table 153. Global Large Volume Parenteral (LVP) Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 154. Global Large Volume Parenteral (LVP) Sales (M Units) Forecast by Application (2021-2026) Table 155. Global Large Volume Parenteral (LVP) Revenue (Million US$) Forecast by Application (2021-2026) Table 156. Global Large Volume Parenteral (LVP) Sales (M Units) Forecast by Region (2021-2026) Table 157. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Region (2021-2026) Table 158. Global Large Volume Parenteral (LVP) Revenue Forecast by Region (2021-2026) (US$ Million) Table 159. Global Large Volume Parenteral (LVP) Revenue Market Share Forecast by Region (2021-2026) Table 160. Research Programs/Design for This Report Table 161. Key Data Information from Secondary Sources Table 162. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Large Volume Parenteral (LVP) Figure 2. Global Large Volume Parenteral (LVP) Sales Market Share by Type: 2020 VS 2026 Figure 3. Soft Bag LVP Product Picture Figure 4. Plastic Bottle LVP Product Picture Figure 5. Glass Bottle LVP Product Picture Figure 6. Global Large Volume Parenteral (LVP) Consumption Market Share by Application: 2020 VS 2026 Figure 7. Basic Infusion Figure 8. Therapeutic Infusion Figure 9. Nutritious Infusion Figure 10. Global Large Volume Parenteral (LVP) Market Size 2015-2026 (US$ Million) Figure 11. Global Large Volume Parenteral (LVP) Sales Capacity (M Units) (2015-2026) Figure 12. Global Large Volume Parenteral (LVP) Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Large Volume Parenteral (LVP) Sales Share by Manufacturers in 2020 Figure 14. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Large Volume Parenteral (LVP) Revenue in 2019 Figure 16. Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2015-2020) Figure 18. Global Large Volume Parenteral (LVP) Sales Market Share by Region in 2019 Figure 19. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2015-2020) Figure 20. Global Large Volume Parenteral (LVP) Revenue Market Share by Region in 2019 Figure 21. North America Large Volume Parenteral (LVP) Sales Market Share by Country in 2019 Figure 22. North America Large Volume Parenteral (LVP) Revenue Market Share by Country in 2019 Figure 23. U.S. Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 24. U.S. Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 26. Canada Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Large Volume Parenteral (LVP) Sales Market Share by Country in 2019 Figure 28. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country in 2019 Figure 29. Germany Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 30. Germany Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 32. France Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 34. U.K. Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 36. Italy Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 38. Russia Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Region in 2019 Figure 40. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Region in 2019 Figure 41. China Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 42. China Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 44. Japan Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 46. South Korea Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 48. India Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 50. Australia Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 52. Taiwan Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 54. Indonesia Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 56. Thailand Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 58. Malaysia Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 60. Philippines Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 62. Vietnam Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Large Volume Parenteral (LVP) Sales Market Share by Country in 2019 Figure 64. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Country in 2019 Figure 65. Mexico Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 66. Mexico Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 68. Brazil Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 70. Argentina Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Country in 2019 Figure 73. Turkey Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 74. Turkey Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 76. Saudi Arabia Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units) Figure 78. U.A.E Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Large Volume Parenteral (LVP) by Type (2015-2020) Figure 80. Sales Market Share of Large Volume Parenteral (LVP) by Type in 2019 Figure 81. Revenue Share of Large Volume Parenteral (LVP) by Type (2015-2020) Figure 82. Revenue Market Share of Large Volume Parenteral (LVP) by Type in 2019 Figure 83. Global Large Volume Parenteral (LVP) Sales Growth by Type (2015-2020) (M Units) Figure 84. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2015-2020) Figure 85. Global Large Volume Parenteral (LVP) Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Large Volume Parenteral (LVP) by Application (2015-2020) Figure 87. Global Revenue Share of Large Volume Parenteral (LVP) by Application in 2020 Figure 88. Baxter Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Kelun Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. B. Braun Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Pfizer (Hospira) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Ostuka Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. CR Double-Crane Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Pisa Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Huaren Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Patheon Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Aspen Holdings Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Beximco Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Cook Pharmica Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Albert David Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. PSI Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Ozon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. BAG Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 106. BML Parenteral Drugs Total Revenue (US$ Million): 2019 Compared with 2018 Figure 107. Price Trend of Key Raw Materials Figure 108. Manufacturing Cost Structure of Large Volume Parenteral (LVP) Figure 109. Manufacturing Process Analysis of Large Volume Parenteral (LVP) Figure 110. Large Volume Parenteral (LVP) Industrial Chain Analysis Figure 111. Channels of Distribution Figure 112. Distributors Profiles Figure 113. Porter's Five Forces Analysis Figure 114. North America Large Volume Parenteral (LVP) Sales (M Units) and Growth Rate Forecast (2021-2026) Figure 115. North America Large Volume Parenteral (LVP) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Europe Large Volume Parenteral (LVP) Sales (M Units) and Growth Rate Forecast (2021-2026) Figure 117. Europe Large Volume Parenteral (LVP) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Latin America Large Volume Parenteral (LVP) Sales (M Units) and Growth Rate Forecast (2021-2026) Figure 119. Latin America Large Volume Parenteral (LVP) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Middle East and Africa Large Volume Parenteral (LVP) Sales (M Units) and Growth Rate Forecast (2021-2026) Figure 121. Middle East and Africa Large Volume Parenteral (LVP) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Asia Pacific Large Volume Parenteral (LVP) Sales (M Units) and Growth Rate Forecast (2021-2026) Figure 123. Asia Pacific Large Volume Parenteral (LVP) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 124. Bottom-up and Top-down Approaches for This Report Figure 125. Data Triangulation Figure 126. Key Executives Interviewed

Baxter Healthcare Kelun Pharma B. Braun Fresenius Teva Pharmaceutical Industries Pfizer (Hospira) Ostuka Pharmaceutical CR Double-Crane Pisa Huaren Patheon Aspen Holdings Beximco Pharma Cook Pharmica Albert David PSI Ltd Ozon Pharmaceuticals BAG Healthcare BML Parenteral Drugs